Wound Management Interventions and Adjunctive Therapies

Key Points

• Wound management combines drainage control, closure protection, cleansing, debridement, and targeted adjunctive therapies.
• Dressing strategy should keep the wound bed moist while protecting surrounding skin from overhydration and adhesive injury.
• Drain type, closure-device status, and exudate trends directly affect escalation timing.
• Discharge outcomes improve when education includes return demonstration, infection-warning recognition, and realistic home-supply planning.

Pathophysiology

Persistent fluid accumulation, necrotic burden, contamination, and mechanical stress delay wound repair by increasing local inflammation and reducing effective tissue regeneration. Interventions that remove excess fluid, reduce bioburden, and protect viable tissue help restore a favorable healing environment.

Adjunctive therapies (for example negative-pressure systems, selected growth factors, and hyperbaric oxygen) are used when routine care is insufficient or when delayed-healing risk is high. In HBOT pathways, pressurized oxygen exposure supports collagen synthesis and can reduce reperfusion-injury burden in selected complex-wound contexts. Wound bed preparation is an iterative nonsequential process (assessment, intervention, and reevaluation) that should include whole-patient factors such as environment, self-care capacity, and health literacy instead of wound-surface findings alone.

Classification

• Drain systems:
  • closed suction systems (for example Jackson-Pratt, Hemovac)
  • open systems (for example Penrose) draining into external absorbent dressings
  • negative-pressure wound therapy (VAC/NPWT) using foam dressing sealed with film and tubing to a vacuum source that removes fluid and helps approximate wound edges
• Closure care domain: Sutures, staples, adhesive support strips, and tension-protection strategies during early tensile-strength recovery.
• Cleansing domain: Approximated-edge versus unapproximated-edge cleaning patterns and irrigation when ordered.
• Debridement domain:
  • autolytic (occlusive-moisture assisted endogenous tissue breakdown)
  • biological (sterile larval therapy for selective necrotic-burden reduction)
  • enzymatic (topical enzyme-assisted)
  • mechanical (external physical removal)
  • sharp/surgical (provider-performed removal of nonviable tissue with instruments)
• Adjunctive-therapy domain:
  • topical recombinant PDGF in selected chronic wounds
  • HBOT for compromised healing patterns (monoplace or multiplace chamber models)
  • NPWT systems (traditional versus single-use/portable) chosen by depth/exudate/goal context
  • ordered heat/cold modalities for symptom and circulation goals

Nursing Assessment

NCLEX Focus

Prioritize drain/closure integrity, infection trends, and whether wound-care intensity matches healing trajectory.

• Assess drain insertion site, securement, output amount/character, and patency at each encounter.
• For closed suction drains, confirm suction is maintained after emptying.
• For open drains, monitor surrounding dressing saturation and local skin integrity.
• For open drains ordered for staged withdrawal, verify sterile pull/trim/resecure workflow per protocol/provider order and document the amount advanced or shortened.
• Assess suture/staple line integrity, erythema, separation risk, and pain escalation.
• Before dressing changes, assess pain and functional tolerance; verify need for ordered premedication.
• Assess wound-cleansing approach match:
  • approximated edges: clean from incision line outward using clean-to-less-clean flow
  • unapproximated edges: cleanse from center outward while protecting newly forming granulation tissue
• Match lower-extremity ulcer care to etiology before selecting compression and dressings:
  • venous-leg-ulcer pattern: irregular exudative medial-lower-leg wounds; prioritize exudate control plus compression when perfusion status allows
  • arterial-ulcer pattern: painful distal dry punched-out lesions; prioritize moist-healing support and avoid compression until arterial adequacy is confirmed
  • diabetic-foot-ulcer pattern: plantar punched-out wound with callused edge; prioritize off-loading, glycemic management support, and debridement coordination
• Apply TIME-aligned reassessment (tissue, infection/inflammation, moisture, edges) when healing progression slows.
• Use TIME domains as a repeating cycle rather than a one-time checklist; reassess tissue, infection/inflammation, moisture, and edge progression after each treatment change.
• Assess whether current wound condition suggests need for debridement escalation or advanced therapy consultation.
• Before debridement selection, screen for modality-specific contraindications (for example hemodynamic instability, bleeding disorders, anticoagulation burden, and poor perfusion).
• Differentiate slough from purulence during reassessment:
  • slough: devitalized fibrinous tissue (yellow/tan, stringy or adherent)
  • purulence: infectious drainage requiring escalation
• Differentiate eschar from scab during wound review:
  • eschar: nonviable devitalized tissue (often brown/black/tan)
  • scab: surface crust formed by coagulated exudate or blood
• Identify consultation triggers for certified wound care nurse involvement, especially complex or nonhealing wounds and coexisting ostomy or incontinence care needs.
• For complex wound pathways, verify interdisciplinary role alignment (for example surgery, bedside nursing, podiatry, physical therapy, and dietitian input) and document ownership of key plan steps.
• Include occupational-therapy input when ADL-related wound protection, safe repositioning/equipment use, or lymphedema-management technique is needed.
• Track patient/caregiver readiness for home care, including ability to perform steps and obtain supplies.
• Screen for cultural and religious constraints that may affect acceptance of wound products (for example animal-derived biologic materials) and escalate for acceptable alternatives when needed.

Nursing Interventions

• Use hand hygiene and ordered precautions consistently; apply sterile technique for procedures requiring sterility (for example dehisced surgical wounds, ordered sterile dressing changes).
• Keep wound bed appropriately moist while protecting periwound skin with barrier strategies.
• Match dressing family to exudate level and tissue fragility:
  • sterile gauze/Kerlix: low-cost option for primary cover or moistened packing; usually requires at least daily changes and should not be left dry on granulation tissue
  • nonadherent or petroleum-impregnated gauze: use over open wounds/skin tears with secondary cover; commonly replaced every 24-48 hours to prevent drying and adherence
  • transparent film: best for shallow minimal-drainage wounds and for securing secondary materials; supports moisture-vapor transmission but has essentially no absorptive capacity
  • hydrocolloid: occlusive moist-healing/autolytic support with moderate absorption (thicker products); generally avoid infected wounds and change about every 3-7 days
  • hydrogel: useful for dry or low-exudate wounds and can reduce pain; usually changed daily while limiting spread onto intact periwound skin
  • silicone-based dressings: atraumatic options for moderate-to-high exudate wounds, including skin tears; sacral/heel shapes can be used for pressure-injury prevention
  • foam: absorptive, nonadherent primary option; often used under compression systems for venous-ulcer exudate control
  • alginate/hydrofiber: high-absorbency option for heavily exudative wounds and full-thickness packing; typically changed daily to every 3 days by saturation and avoided in dry wounds
• For heavily draining wounds, use high-absorbency options (for example alginate or hydrofiber dressings) and adjust change frequency to prevent periwound maceration.
• Avoid hydrofiber dressings in dry wounds or wound beds dominated by eschar and do not use as primary coverage over third-degree-burn tissue.
• For contact-layer selection, reserve use for clean wound beds; avoid viscous-exudate, undermined/tunneled, or third-degree-burn contexts where contact layers can trap burden.
• For transparent adhesive films in fragile older skin, use adhesive-remover support during removal to reduce skin-tear risk.
• For compression-wrap workflows (for example Coban/Tubigrip), verify distal perfusion before application and recheck pulse/perfusion regularly; avoid compression directly over infected areas or exposed bone/organ structures unless specifically ordered.
• For silver-impregnated antimicrobial dressings, maintain ordered contact time (commonly at least about 24 hours) to preserve antimicrobial effect, and monitor for silver sensitivity/pain complaints.
• Cadexomer-iodine dressings can provide sustained antimicrobial release and are often changed about every 72 hours by exudate burden; avoid with iodine/shellfish/dye hypersensitivity and in very dry wounds where activation is limited.
• For medical-honey dressings, verify no honey allergy and monitor wear interval (often up to about 7 days when exudate and product type allow).
• For topical sulfonamide burn-anti-infective regimens, use gloves and aseptic technique during application and avoid airtight occlusive dressings unless specifically ordered.
• Silver nitrate may be ordered for chemical cauterization/hemostasis in hypergranulation or epibole patterns; apply only after provider assessment and order verification.
• For dressing changes, optimize comfort and dignity:
  • explain steps before care
  • provide privacy and limited exposure
  • position for comfort and safe access
  • use ordered analgesia timing (commonly about 30-60 minutes before painful care)
• During closure-device removal workflows, follow sterile setup and staged removal checks (for example removing alternating sutures/staples first to verify edge stability per protocol/order).
• Recognize closure-removal timing variability by wound/site and patient factors (for example nutrition/age); even after early suture removal, collagen remodeling continues for weeks and scar-widening risk persists under tension.
• Use ordered irrigation solutions and sterile equipment for open-wound irrigation; reassess drainage and tissue response after irrigation.
• Use normal saline as standard cleansing solution unless alternate ordered; other noncytotoxic options can include commercial wound cleansers or potable tap water per policy.
• For dirty or infected wounds, use ordered irrigation force sufficient for debris reduction (commonly about 4-15 psi depending on technique and wound context).
• Avoid routine use of cytotoxic cleansing agents (for example hydrogen peroxide, povidone-iodine, or acetic acid) unless specifically ordered for a defined indication.
• If ordered for infected or heavily necrotic wounds, use antiseptic options (for example Dakin solution or acetic acid) as temporary cleansing support until wound-bed bioburden is controlled.
• For deep or tunneled wounds, pack dead space with ordered moisture-supportive materials (for example saline-moistened gauze or hydrogel-impregnated packing) and avoid tightly packed fills that can damage fragile granulation tissue.
• For gauze packing, use “fluff not stuff” technique to fill dead space without creating perfusion-compromising pressure.
• For rolled, undermined, or tunneled wound edges (for example epibole patterns), use edge-focused reassessment and ordered debridement/packing strategy to restore closure progression.
• Support ordered debridement pathway and document tissue response, bleeding, and tolerance after each session.
• For prescribed enzymatic debridement (for example collagenase), follow ordered application frequency and replace dressings earlier when soiled.
• For enzymatic debridement, verify no contraindicating context (active wound infection, concurrent silver use, or known hypersensitivity to product ingredients).
• For autolytic debridement, reassess early response; if meaningful improvement is absent within about 1-2 days when rapid necrotic reduction is needed, escalate to another modality.
• For biological (larval) debridement, protect containment setup (bagged or free-range per order), monitor tolerance, and reassess necrotic-burden response at each dressing interval.
• Avoid biological debridement in contraindicated patterns (for example pyoderma-gangrenosum wounds during immunosuppression therapy or wounds adjacent to the intraperitoneal cavity) unless specialist-directed.
• Do not routinely remove stable, dry heel eschar until vascular status and provider/wound-team direction are clarified.
• Treat dry stable eschar as a contraindication to routine debridement unless instability or overt infection appears.
• Use extra caution in poor-perfusion states (for example arterial-insufficiency patterns) before debridement escalation.
• If wet-to-dry debridement is ordered, protect moisture balance and avoid leaving dry gauze in the wound bed because excessive drying can disrupt granulation/angiogenesis.
• For pulse-lavage or other high-pressure irrigation workflows, follow ordered pressure range (commonly about 8-12 psi; for example 35 mL syringe with 19-gauge angiocatheter) and use PPE because fluid aerosolization can increase contamination risk.
• When removing alginate dressings, recognize that slight green tint can occur and is not by itself diagnostic of purulent drainage.
• If wounds are intentionally managed open to air, monitor for drying/eschar formation and slower-healing trajectory; protect from friction or accidental trauma.
• For frequent dressing reaccess, use skin-protective securement options (for example Montgomery strap workflow with barrier protection under adhesive surfaces) to reduce retaping injury.
• Choose tape based on skin condition, moisture exposure, and fixation needs:
  • transpore: durable and breathable but can leave residue and irritate fragile skin
  • micropore paper: gentler with low residue but weaker on irregular/wet areas
  • cloth: strong fixation for high-hold needs (for example splint support) but less flexible and not waterproof
  • waterproof tape: useful on dry skin when moisture resistance is needed; can adhere poorly over hair
• Reassess wounds that become increasingly painful for infection or dehiscence before continuing routine dressing workflows.
• For HBOT pathways, verify chamber model (monoplace versus multiplace), expected session duration (commonly about 2 hours), and indication match (for example radiation injury, necrotizing infection, crush injury, selected burns, gas gangrene).
• Treat untreated pneumothorax as a major HBOT contraindication and escalate other risk contexts (for example severe claustrophobia, COPD, seizure history, fever, recent ear injury/surgery, or implanted-device concerns) before chamber entry.
• For HBOT safety, enforce fire-risk restrictions in oxygen-rich environments (for example no flammable oils/perfumes, no lighters/battery devices, and use facility-approved cotton garments).
• For NPWT pathways, maintain airtight seal integrity, prescribed suction settings (commonly about 75-145 mmHg), and near-continuous wear schedule unless paused by order/protocol.
• Plan NPWT dressing changes by stability/exudate (commonly every 48-72 hours); single-use portable systems may remain in place for up to about 7 days when stable.
• In NPWT selection, match system type to wound profile:
  • traditional systems: open-cell foam filler, occlusive cover layer, tubing, canister/fluid collection, and suction source
  • single-use portable systems: usually for incision management or shallow difficult-to-heal wounds with lower device burden
• Screen NPWT contraindications before escalation (for example untreated osteomyelitis, active sepsis, coagulopathy burden, unexplored fistula, or material allergy).
• In NPWT workflows, do not place foam directly on exposed blood vessels, anastomotic sites, organs, or nerves; consider premedication for painful dressing changes when ordered.
• For heat/cold use, apply time and skin-safety limits to avoid burns, overhydration, or cold injury.
• Deliver discharge-ready wound teaching with return demonstration:
  • hand hygiene and glove-use workflow
  • infection-warning signs and when to notify provider
  • dressing disposal method
  • nutrition/hydration support for healing
  • activity and follow-up expectations
• When clinically appropriate, reinforce hydration goals often used in wound self-care plans (about 48-64 ounces/day) and encourage planned rest periods to avoid overexertion-related reinjury.
• Tailor teaching materials to patient literacy and preferred language; include family/caregiver in demonstration when home support is expected.
• Include practical supply-planning guidance (access, cost, insurance coverage options, and preferred local sourcing) to prevent home-care interruption.
• When biologic graft or skin-substitute products are considered, disclose animal-derived ingredients and confirm patient preferences before application.

Progression Risk

Inadequate reassessment of drain output, closure stability, or infection cues can delay escalation and increase risk of dehiscence, abscess, or systemic deterioration.

Pharmacology

Drug/Class Context	Examples	Key Nursing Considerations
analgesics	Acetaminophen, ordered opioid options	Improve tolerance for wound care and movement while monitoring adverse effects.
Topical growth factor context	Recombinant platelet-derived growth factor (PDGF)	Apply only when ordered and monitor wound-bed response and local tolerance.
antibiotics	Culture-guided agents; topical options such as silver sulfadiazine when ordered	Correlate treatment with infection cues and wound-culture data; when burn sulfonamide creams are used, choose nonocclusive secondary coverage unless specifically ordered otherwise.

Clinical Judgment Application

Clinical Scenario

A postoperative patient with an abdominal incision has rising drain output, increased pain during dressing change, and new concern about managing care at home.

• Recognize Cues: Drain trend change, procedural pain burden, and low self-care confidence.
• Analyze Cues: Healing trajectory may be destabilizing without targeted intervention and education reinforcement.
• Prioritize Hypotheses: Highest priorities are complication prevention and safe discharge readiness.
• Generate Solutions: Reassess wound/drain status, optimize analgesia timing, reinforce sterile/clean technique expectations, and perform return-demonstration teaching.
• Take Action: Escalate abnormal findings, implement revised care plan, and verify patient/caregiver skill competence.
• Evaluate Outcomes: Drain trend stabilizes, wound care is tolerated, and home-care steps are performed correctly.

Related Concepts

• wound-assessment-tools-and-documentation-standards - Serial measurement and charting standards guide intervention adjustments.
• simple-wound-dressing-change - Stepwise clean/sterile dressing-change workflow and contamination-control sequence.
• closed-suction-drain-management - Hemovac/JP reservoir-emptying workflow, suction reestablishment, and drain-output trend documentation.
• wound-cleansing-irrigation-and-packing - Complex secondary-intention workflow for irrigation pressure control, safe packing depth, and moisture-balance protection.
• intermittent-suture-removal - Staged nonabsorbable suture-removal workflow with dehiscence-prevention checks.
• staple-removal - Sterile extractor-based staple-removal technique with alternating removal and Steri-Strip support.
• wound-culture-specimen-collection - Contamination-controlled wound swab collection workflow for culture/susceptibility guidance.
• wound-healing-phases-and-closure-intentions - Phase expectations inform timing and escalation decisions.
• delayed-wound-healing-factors-and-complications - Complication clusters and systemic barriers shape intervention intensity.
• pressure-injury-staging-and-risk-assessment - Pressure-offloading and stage-based wound care priorities.
• teach-back-method-in-nursing-education - Confirms home wound-care understanding and skill reliability.

Self-Check

1. Which drain findings indicate reassessment and possible provider escalation?
2. How do cleansing approaches differ between approximated and unapproximated wounds?
3. Which elements must be verified before discharge for safe home wound management?